CD8A and glioblastoma: Radiation therapy combined with VEGFC activates CCL21, promotes the transport of DCs, and increases the number of CD8+Ki67+ T cells, Treg cells, and overall CD8+ T cells in CLN, thus showing a higher sensitivity to GBM and metastatic brain tumors [12].